These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27906834)

  • 1. Successful Continuation of HCV Treatment After Liver Transplantation.
    Fernández Carrillo C; Crespo G; de la Revilla J; Castells L; Buti M; Montero JL; Fábrega E; Fernández I; Serrano-Millán C; Hernández V; Calleja JL; Londoño MC
    Transplantation; 2017 May; 101(5):1009-1012. PubMed ID: 27906834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients.
    Cholongitas E; Pipili C; Papatheodoridis G
    World J Gastroenterol; 2015 Aug; 21(32):9526-33. PubMed ID: 26327760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post-liver transplantation?
    Barsa JE; Branch AD; Schiano TD
    Clin Transplant; 2015 Oct; 29(10):859-65. PubMed ID: 26329668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatitis C infection before and after liver transplantation.
    Fagiuoli S; Ravasio R; Lucà MG; Baldan A; Pecere S; Vitale A; Pasulo L
    World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum timing of treatment for hepatitis C infection relative to liver transplantation.
    Coilly A; Roche B; Duclos-Vallée JC; Samuel D
    Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):165-172. PubMed ID: 28404073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No need to discontinue hepatitis C virus therapy at the time of liver transplantation.
    Skoglund C; Lagging M; Castedal M
    PLoS One; 2019; 14(2):e0211437. PubMed ID: 30794555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation.
    Vitale A; Spolverato G; Burra P; De Feo TM; Belli L; Donato F; Baroni GS; Marianelli T; Picciotto A; Toniutto P; Bhoori S; Passigato N; Lucà MG; Russo FP; Cillo U; Fagiuoli S;
    Transpl Int; 2015 Sep; 28(9):1055-65. PubMed ID: 25865602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence.
    Poordad F; Schiff ER; Vierling JM; Landis C; Fontana RJ; Yang R; McPhee F; Hughes EA; Noviello S; Swenson ES
    Hepatology; 2016 May; 63(5):1493-505. PubMed ID: 26754432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
    Fontana RJ; Brown RS; Moreno-Zamora A; Prieto M; Joshi S; Londoño MC; Herzer K; Chacko KR; Stauber RE; Knop V; Jafri SM; Castells L; Ferenci P; Torti C; Durand CM; Loiacono L; Lionetti R; Bahirwani R; Weiland O; Mubarak A; ElSharkawy AM; Stadler B; Montalbano M; Berg C; Pellicelli AM; Stenmark S; Vekeman F; Ionescu-Ittu R; Emond B; Reddy KR
    Liver Transpl; 2016 Apr; 22(4):446-58. PubMed ID: 26890629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation: Two-Center Experience.
    Elfeki MA; Abou Mrad R; Modaresi Esfeh J; Zein NN; Eghtesad B; Zervos X; Hanouneh IA; O'Shea R; Carey WD; Alkhouri N
    Transplantation; 2017 May; 101(5):996-1000. PubMed ID: 27631598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.
    Fernández Carrillo C; Lens S; Llop E; Pascasio JM; Crespo J; Arenas J; Fernández I; Baliellas C; Carrión JA; de la Mata M; Buti M; Castells L; Albillos A; Romero M; Turnes J; Pons C; Moreno-Planas JM; Moreno-Palomares JJ; Fernández-Rodriguez C; García-Samaniego J; Prieto M; Fernández Bermejo M; Salmerón J; Badia E; Salcedo M; Herrero JI; Granados R; Blé M; Mariño Z; Calleja JL
    Hepatology; 2017 Jun; 65(6):1810-1822. PubMed ID: 28170112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease.
    Herzer K; Welzel TM; Spengler U; Hinrichsen H; Klinker H; Berg T; Ferenci P; Peck-Radosavljevic M; Inderson A; Zhao Y; Jimenez-Exposito MJ; Zeuzem S
    Transpl Int; 2017 Mar; 30(3):243-255. PubMed ID: 28012215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late.
    Pellicelli AM; Montalbano M; Lionetti R; Durand C; Ferenci P; D'Offizi G; Knop V; Telese A; Lenci I; Andreoli A; Zeuzem S; Angelico M
    Dig Liver Dis; 2014 Oct; 46(10):923-7. PubMed ID: 24997638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
    Price JC; Terrault NA
    Liver Transpl; 2015 Apr; 21(4):423-34. PubMed ID: 25604355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy.
    Bunchorntavakul C; Reddy KR
    J Viral Hepat; 2016 Jun; 23(6):408-18. PubMed ID: 27018088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of recurrent hepatitis C virus after liver transplantation.
    Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
    World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.
    Dumortier J; Leroy V; Duvoux C; de Ledinghen V; Francoz C; Houssel-Debry P; Radenne S; d'Alteroche L; Fougerou-Leurent C; Canva V; di Martino V; Conti F; Kamar N; Moreno C; Lebray P; Tran A; Besch C; Diallo A; Rohel A; Rossignol E; Abergel A; Botta-Fridlund D; Coilly A; Samuel D; Duclos-Vallée JC; Pageaux GP
    Liver Transpl; 2016 Oct; 22(10):1367-78. PubMed ID: 27348086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Martin MT; Koppe S
    Transplantation; 2017 Sep; 101(9):2088-2091. PubMed ID: 28376038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral hepatitis C and organ transplantation].
    Husová L; Mejzlík V
    Vnitr Lek; 2017; 63(7-8):531-534. PubMed ID: 28933180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.